[PMID: 18553477] PubMed record related to this compound for laboratory literature review
Second Natures peer-reviewed study published in JMIR Formative Research (2025) compared both medications within our programme: 3 Tirzepatide (Mounjaro) cohort (209 people): 22.1% average weight loss at 12 months 95.2% achieved at least 10% weight loss 83.7% achieved at least 15% weight loss Semaglutide (Wegovy) cohort (130 people): 17.1% average weight loss at 12 months 83.1% achieved at least 10% weight loss 56.2% achieved at least 15% weight loss Both cohorts exceeded clinical trial results, suggesting that comprehensive behavioural support enhances outcomes regardless of which medication you use
Weight loss relieves pressure on the weight-bearing joints, says Brandie Burckhard, nurse practitioner and obesity medicine specialist at HonorHealth General Surgery - Tempe
Medication users need regular followups, lab checks, and dose adjustments
The company echoes the early days of Oak Street Health , a high-touch primary-care network later acquired by CVS for $10.6 billion
DSIP or Deltaran was dissolved in double distilled water and added directly to the polarographic cuvette